Custom enzymes,
strains, and processes
for practical
biomanufacturing
Evolutia Bio develops proprietary biomanufacturing solutions for ingredient and industrial partners. Combined with Mycofeast’s scale-up and manufacturing capabilities, we provide a more complete path from concept to commercial production.
Formerly Willow Biosciences / Epimeron Inc, acquired by Mycofeast in 2025
What We Do
Built around commercial
outcomes, not just discovery
Evolutia Bio develops custom enzymes, engineered strains, and biomanufacturing processes for partners seeking more efficient, scalable, and commercially viable production routes.
Industries
Food & Ingredients
Functional ingredients, specialty molecules, fermentation-enabled products.
Agriculture
Biobased processes for active ingredients and performance-enhancing compounds.
Pharma & Fine Chemicals
Custom enzyme, strain, and process development for high-value targets.
Industrial Biomanufacturing
Commercially relevant process design where biology creates a better route.
EVOLUTIA × MYCOFEAST
A more complete route from development to production
In biomanufacturing, one of the hardest steps is turning a promising lab result into a process that can scale and stand up commercially.
Evolutia and Mycofeast work together to tackle that challenge by turning novel biology into scalable biomanufacturing processes that perform beyond the lab.
↕ DEVELOPMENT → MANUFACTURING ↕
Team
